Form 8-K - Current report:
SEC Accession No. 0001104659-25-048160
Filing Date
2025-05-14
Accepted
2025-05-14 07:11:58
Documents
15
Period of Report
2025-05-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2515019d1_8k.htm   iXBRL 8-K 24495
2 EXHIBIT 99.1 tm2515019d1_ex99-1.htm EX-99.1 73096
6 GRAPHIC tm2515019d1_ex99-1img01.jpg GRAPHIC 5292
  Complete submission text file 0001104659-25-048160.txt   290633

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mist-20250514.xsd EX-101.SCH 3035
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mist-20250514_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mist-20250514_pre.xml EX-101.PRE 22372
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2515019d1_8k_htm.xml XML 3816
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38899 | Film No.: 25942624
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)